iTL/ATGC awarded NIH Phase I SBIR grant to develop rabbit expressing single chain antibodies
Heavy chain only antibodies are naturally produced in camelids and sharks. They have found many advantages in research, diagnostics and ... Read More
ATGC awarded NIH Phase I STTR grant to develop pluripotent rabbit embryonic stem cell line
Pluripotent embryonic stem cell is the critical ingredient for making complicated genetically engineered animals, which can be used for the ... Read More
ATGC awarded NIH Phase I STTR grant to develop novel method to improve nuclease mediated homologous recombination
Homologous recombination is the major biological mechanism underlying the gene correction and genetic modification using programmable nucleases such as CRISPR/Cas9. ... Read More